Morgan Stanley Compugen LTD Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Compugen LTD stock. As of the latest transaction made, Morgan Stanley holds 755,847 shares of CGEN stock, worth $1.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

755,847

Previous 753,935 0.25%

Holding current value

$1.13 Million

Previous $1.27 Million 8.06%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.56 - $2.1 $2,982 - $4,015	1,912 Added 0.25%	755,847 $1.37 Million
Q2 2024 Oct 17, 2024	SELL	$1.68 - $2.52 $11,872 - $17,808	-7,067 Reduced 0.93%	753,935 $1.27 Million
Q2 2024 Aug 14, 2024	SELL	$1.68 - $2.52 $11,872 - $17,808	-7,067 Reduced 0.93%	753,935 $1.27 Million
Q1 2024 Oct 17, 2024	BUY	$1.75 - $2.95 $12,367 - $20,847	7,067 Added 0.94%	761,002 $1.96 Million
Q1 2024 Aug 16, 2024	SELL	$1.75 - $2.95 $18,667 - $31,467	-10,667 Reduced 1.38%	761,002 $1.96 Million
Q1 2024 May 15, 2024	SELL	$1.75 - $2.95 $18,667 - $31,467	-10,667 Reduced 1.38%	761,002 $1.96 Million
Q4 2023 Aug 16, 2024	BUY	$0.53 - $2.0 $9,399 - $35,468	17,734 Added 2.35%	771,669 $1.53 Million
Q4 2023 Feb 13, 2024	SELL	$0.53 - $2.0 $6,189 - $23,356	-11,678 Reduced 1.49%	771,669 $1.53 Million
Q3 2023 Nov 15, 2023	BUY	$0.88 - $1.31 $4,374 - $6,512	4,971 Added 0.64%	783,347 $728,000
Q2 2023 Aug 14, 2023	SELL	$0.57 - $1.38 $7,877 - $19,072	-13,821 Reduced 1.74%	778,376 $887,000
Q1 2023 May 15, 2023	BUY	$0.68 - $1.11 $35,217 - $57,488	51,791 Added 6.99%	792,197 $554,000
Q4 2022 Feb 14, 2023	SELL	$0.58 - $1.2 $191,204 - $395,595	-329,663 Reduced 30.81%	740,406 $533,000
Q3 2022 Nov 14, 2022	SELL	$0.66 - $2.32 $33,438 - $117,540	-50,664 Reduced 4.52%	1,070,069 $704,000
Q2 2022 Oct 27, 2022	SELL	$1.57 - $3.33 $98,906 - $209,783	-62,998 Reduced 5.32%	1,120,733 $2.08 Million
Q2 2022 Aug 15, 2022	SELL	$1.57 - $3.33 $98,906 - $209,783	-62,998 Reduced 5.32%	1,120,733 $2.08 Million
Q1 2022 Oct 27, 2022	BUY	$2.76 - $4.64 $173,874 - $292,310	62,998 Added 5.62%	1,183,731 $3.81 Million
Q1 2022 May 13, 2022	SELL	$2.76 - $4.64 $272,809 - $458,636	-98,844 Reduced 7.71%	1,183,731 $3.81 Million
Q4 2021 Feb 14, 2022	SELL	$4.09 - $7.16 $1.39 Million - $2.44 Million	-340,723 Reduced 20.99%	1,282,575 $5.52 Million
Q3 2021 Nov 15, 2021	BUY	$5.8 - $8.02 $9.42 Million - $13 Million	1,623,298 New	1,623,298 $9.69 Million

Others Institutions Holding CGEN

# of Institutions

Shares Held

13.1M

Call Options Held

79.2K

Put Options Held

12.7K

View Full List

About COMPUGEN LTD

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $129M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

More about CGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account